Cancer Drugs, AI Prescribing, and Health Costs

Kilder

• STAT: STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
• STAT: STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
• STAT: STAT+: Divergent trial results on cancer vaccines have the field grappling with hard questions
• STAT: Lilly’s Jaypirca approved as first-line CLL therapy - STAT
• STAT: STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
• Beckershospitalreview: Utah approves 1st AI pilot to issue initial prescriptions
• Kff: As HHS Restores the LGBTQ 988 Suicide and Crisis Line Under Pressure From Congress, Questions Remain
• STAT: Hospital and pharmaceutical prices are smothering America’s businesses
• STAT: New Trump regulations would clean up health care pricing disclosures - STAT
• Thehill: Appeals court to hear lawsuit against RFK Jr. vaccine moves - The Hill

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.